Steven Howard
36Patents
8h-index
117Co-inventors
78Inventor score
Filing activity: Mar 29, 2001 → Jan 25, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8685980B2 | Pyrrolopyrimidine compounds and their uses | Human Necessities | 27 | Active |
| US7977477B2 | Benzimidazole derivatives and their use as protein kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US7056491B2 | Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators | Human Necessities | 17 | Expired |
| US9155743B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 13 | Active |
| US9018214B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 13 | Active |
| US9458158B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 12 | Active |
| US9617248B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 10 | Active |
| US9617283B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 10 | Active |
| US9676768B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 8 | Active |
| US9663512B2 | Bicyclic heterocycle compounds and their uses in therapy | Chemistry; Metallurgy | 8 | Active |
| US9783538B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 7 | Active |
| US10544132B2 | Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity | Chemistry; Metallurgy | 7 | Active |
| US10526311B2 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Chemistry; Metallurgy | 6 | Active |
| US9980973B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 5 | Active |
| US8110573B2 | Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases | Chemistry; Metallurgy | 5 | Active |
| US10618895B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 4 | Active |
| US10457669B2 | Benzolactam compounds as protein kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10981898B2 | Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity | Chemistry; Metallurgy | 4 | Active |
| US11225476B2 | Bicyclic heterocycle compounds and their uses in therapy | Human Necessities | 3 | Active |
| US9416136B2 | Pyrrolopyrimidine compounds and their uses | Human Necessities | 3 | Active |
| US11001575B1 | Benzolactam compounds as protein kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US6878704B2 | Heterocyclic mutilin esters and their use as antibacterials | Chemistry; Metallurgy | 2 | Expired |
| US8778936B2 | Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases | Chemistry; Metallurgy | 2 | Active |
| US11603367B2 | Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them | Chemistry; Metallurgy | 2 | Active |
| US11261171B1 | Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.